Skip to main content
SpringerLink
Log in

Sex and Gender Differences in Hematology

  • Chapter
  • First Online:
Sex and Gender Aspects in Clinical Medicine

Abstract

Receiving the diagnosis of cancer presents always a severe crisis in the individual biography, challenging every aspect of normal life, including personal emotions, aims and future plans, family, relationships, careers, and financial matters. Many issues of everyday life are known to be gender related, and as such interfere with the coping abilities of the affected persons. Gender roles and aspects are fundamentally implemented in all layers of everyday life and in living with cancer. Some differences seem to have an especially deep impact.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood. 1976;48(3):449.

    PubMed  CAS  Google Scholar 

  2. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277(12):973.

    Article  PubMed  CAS  Google Scholar 

  3. Brittenham G. Disorders of iron metabolism: iron deficiency and overload. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al., eds. Hematology Basic Principles and Practice. New York: Churchill Livingstone; 2005:481.

    Google Scholar 

  4. El-Maarri O, Becker T, Junen J, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet. 2007;122(5):505.

    Article  PubMed  CAS  Google Scholar 

  5. Merkel D, Moran DS, Yanovich R, et al. The association between hematological and inflammatory factors and stress fractures among female military recruits. Med Sci Sports Exerc. 2008;40(11 Suppl):S691.

    PubMed  Google Scholar 

  6. Bain Barbara J. Blood Cells. A Practical Guide. London: Blackwell Science; 2002.

    Google Scholar 

  7. Nordin G, Martensson A, Swolin B, et al. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest. 2004; 64(4):385.

    Article  PubMed  CAS  Google Scholar 

  8. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7(2):145.

    Article  PubMed  CAS  Google Scholar 

  9. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052.

    PubMed  CAS  Google Scholar 

  10. Steinberg MH, Hsu H, Nagel RL, et al. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol. 1995;48(3):175.

    Article  PubMed  CAS  Google Scholar 

  11. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Relationship between hematocrit and renal function in men and women. Kidney Int. 2001;59(2):725.

    Article  PubMed  CAS  Google Scholar 

  12. Crooks CJ, West J, Solaymani-Dodaran M, Card TR. The epidemiology of haemochromatosis: a population-based study. Aliment Pharmacol Ther. 2009;29(2):183.

    Article  PubMed  CAS  Google Scholar 

  13. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280(2):172.

    Article  PubMed  CAS  Google Scholar 

  14. Deugnier Y, Jouanolle AM, Chaperon J, et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol. 2002;118(4):1170.

    Article  PubMed  CAS  Google Scholar 

  15. Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception. 2002;65(3):197.

    Article  PubMed  CAS  Google Scholar 

  16. Lidegaard O. Thrombotic diseases in young women and the influence of oral contraceptives. Am J Obstet Gynecol. 1998;179(3 Pt 2):S62.

    Article  PubMed  CAS  Google Scholar 

  17. Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de Wolf JT. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg. 2010;110(4):987.

    Article  PubMed  Google Scholar 

  18. Gorton HJ, Warren ER, Simpson NA, Lyons GR, Columb MO. Thromboelastography identifies sex-related differences in coagulation. Anesth Analg. 2000;91(5):1279.

    PubMed  CAS  Google Scholar 

  19. Cahill M, Mistry R, Chapman C, Wood JK, Barnett DB. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa). Br J Clin Pharmacol. 1992;33(1):11.

    PubMed  CAS  Google Scholar 

  20. Tsang CW, Lazarus R, Smith W, Mitchell P, Koutts J, Burnett L. Hematological indices in an older population sample: derivation of healthy reference values. Clin Chem. 1998; 44(1):96.

    PubMed  CAS  Google Scholar 

  21. Moysidis T, Kroger K, Moerchel C, Santosa F, Grochenig E. Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis. 2010;21(6):511.

    Article  PubMed  Google Scholar 

  22. Kroger K, Moerchel C, Moysidis T, Santosa F. Incidence rate of pulmonary embolism in Germany: data from the federal statistical office. J Thromb Thrombolysis. 2010;29(3):349.

    Article  PubMed  CAS  Google Scholar 

  23. Blanco-Molina A, Trujillo-Santos J, Tirado R, et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb Haemost. 2009;101(3):478.

    PubMed  CAS  Google Scholar 

  24. Sakuma M, Nakamura M, Takahashi T, et al. Pulmonary embolism is an important cause of death in young adults. Circ J. 2007;71(11):1765.

    Article  PubMed  Google Scholar 

  25. Stein PD, Huang H, Afzal A, Noor HA. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race. Chest. 1999;116(4):909.

    Article  PubMed  CAS  Google Scholar 

  26. Laczkovics C, Grafenhofer H, Kaider A, et al. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica. 2007;92(9):1201.

    Article  PubMed  Google Scholar 

  27. Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108(9):2937.

    Article  PubMed  CAS  Google Scholar 

  28. Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1988–1997: the fall may approach 80,000 deaths a year. Int J Cancer. 2002;98(4):636.

    Article  PubMed  CAS  Google Scholar 

  29. Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma. 2006;47(8):1477.

    Article  PubMed  Google Scholar 

  30. Kravdal O, Hansen S. Hodgkin’s disease: the protective effect of childbearing. Int J Cancer. 1993;55(6):909.

    Article  PubMed  CAS  Google Scholar 

  31. Chen WY, Zeng X, Carter MG, et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet. 2003;33(2):197.

    Article  PubMed  CAS  Google Scholar 

  32. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature. 2007;450(7170):721.

    Article  PubMed  CAS  Google Scholar 

  33. Hu W, Feng Z, Atwal GS, Levine AJ. p53: a new player in reproduction. Cell Cycle. 2008;7(7):848.

    Article  PubMed  CAS  Google Scholar 

  34. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121.

    Article  PubMed  CAS  Google Scholar 

  35. Sander LE, Trautwein C, Liedtke C. Is interleukin-6 a gender-specific risk factor for liver cancer? Hepatology. 2007;46(4):1304.

    Article  PubMed  CAS  Google Scholar 

  36. Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol. 2008;48(2):380.

    Article  PubMed  CAS  Google Scholar 

  37. Balbin M, Fueyo A, Tester AM, et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003;35(3):252.

    Article  PubMed  CAS  Google Scholar 

  38. Gazzeri R, Galarza M, Gazzeri G. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med. 2007;357(23):2411.

    Article  PubMed  CAS  Google Scholar 

  39. Mossuz P, Cousin F, Castinel A, et al. Effects of two sex steroids (17beta estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937. Leuk Res. 1998;22(11):1063.

    Article  PubMed  CAS  Google Scholar 

  40. Durcova-Hills G, Hajkova P, Sullivan S, Barton S, Surani MA, McLaren A. Influence of sex chromosome constitution on the genomic imprinting of germ cells. Proc Natl Acad Sci USA. 2006;103(30):11184.

    Article  PubMed  CAS  Google Scholar 

  41. Van Vlierberghe P, Palomero T, Khiabanian H, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010;42(4):338.

    Article  PubMed  Google Scholar 

  42. Bolufer P, Collado M, Barragan E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica. 2007;92(3):308.

    Article  PubMed  CAS  Google Scholar 

  43. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol. 2002;118(4):1071.

    Article  PubMed  Google Scholar 

  44. Jentsch-Ullrich K, Koenigsmann M, Mohren M, Franke A. Lymphocyte subsets’ reference ranges in an age- and gender-balanced population of 100 healthy adults – a monocentric German study. Clin Immunol. 2005;116(2):192.

    Article  PubMed  CAS  Google Scholar 

  45. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Reproductive factors in Hodgkin’s disease in women. Am J Epidemiol. 2003;158(6):553.

    Article  PubMed  Google Scholar 

  46. Pui CH, Boyett JM, Relling MV, et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol. 1999;17(3):818.

    PubMed  CAS  Google Scholar 

  47. Robak T, Szmigielska-Kaplon A, Wrzesien-Kus A, et al. Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience. Ann Hematol. 2004;83(4):225.

    Article  PubMed  CAS  Google Scholar 

  48. Somigliana E, Vigano P, Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update. 1999;5(1):40.

    Article  PubMed  CAS  Google Scholar 

  49. Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer. Br J Cancer. 2005;92(11):1959.

    Article  PubMed  CAS  Google Scholar 

  50. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987.

    Google Scholar 

  51. Coiffier B, Gisselbrecht C, Vose JM, et al. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d’Etudes des Lymphomes Agressifs. J Clin Oncol. 1991;9(2):211.

    PubMed  CAS  Google Scholar 

  52. Osby E, Askling J, Landgren O, Dickman PW, Ekbom A, Bjorkholm M. Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin’s lymphoma. Acta Oncol. 2004;43(3):297.

    Article  PubMed  Google Scholar 

  53. Hasselblom S, Ridell B, Nilsson-Ehle H, Andersson PO. The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma – a population-based study. Leuk Lymphoma. 2007;48(4):736.

    Article  PubMed  Google Scholar 

  54. Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39.

    Article  PubMed  Google Scholar 

  55. Catovsky D, Matutes E, Dearden C, Osuji N, Brito-Babapulle V. The WHO classification of mature T-cell leukemias. Blood. 2004;104(9):2989.

    Article  PubMed  CAS  Google Scholar 

  56. Wohl Y, Golan H, Brenner S. Cutaneous lymphomas and association to sex hormones. Skinmed. 2003;2(5):312.

    Article  PubMed  Google Scholar 

  57. Gregersen H, Mellemkjaer L, Ibsen JS, Dahlerup JF, Thomassen L, Sorensen HT. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Haematologica. 2001;86(11):1172.

    PubMed  CAS  Google Scholar 

  58. Sokal JE, Baccarani M, Tura S, et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 1985;66(6):1352.

    PubMed  CAS  Google Scholar 

  59. Lee JP, Birnstein E, Masiello D, Yang D, Yang AS. Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study. J Hematol Oncol. 2009;2:30.

    Article  PubMed  CAS  Google Scholar 

  60. Berger U, Maywald O, Pfirrmann M, et al. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. Leukemia. 2005;19(6):984.

    Article  PubMed  CAS  Google Scholar 

  61. Ribeiro RC, Razzouk BI, Pounds S, Hijiya N, Pui CH, Rubnitz JE. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children’s Research Hospital, from 1980 to 2000. Leukemia. 2005;19(12):2125.

    Article  PubMed  CAS  Google Scholar 

  62. Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer. 2009; 9:252.

    Article  PubMed  Google Scholar 

  63. Wong O, Harris F, Yiying W, Hua F. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification. Regul Toxicol Pharmacol. 2009;55(3):340.

    Article  PubMed  Google Scholar 

  64. Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction. 2008;136(6):691.

    Article  PubMed  CAS  Google Scholar 

  65. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin’s disease. N Engl J Med. 1981;304(23):1377.

    Article  PubMed  CAS  Google Scholar 

  66. Tao T, Del Valle A. Human oocyte and ovarian tissue cryopreservation and its application. J Assist Reprod Genet. 2008;25(7):287.

    Article  PubMed  Google Scholar 

  67. Varghese AC, du Plessis SS, Falcone T, Agarwal A. Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation. Reprod Biol Endocrinol. 2008;6:47.

    Article  PubMed  Google Scholar 

  68. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279.

    PubMed  Google Scholar 

  69. Azim HA Jr, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat Rev. 2010;36(2):110.

    Article  PubMed  CAS  Google Scholar 

  70. Jones PR, Wilkinson S, Davies PS. A revision of body surface area estimations. Eur J Appl Physiol Occup Physiol. 1985;53(4):376.

    Article  PubMed  CAS  Google Scholar 

  71. Marosi C. Gender aspects of treatment and drug related toxicity in medical oncology. Wien Med Wochenschr. 2006;156(19–20):534.

    Article  PubMed  Google Scholar 

  72. Dobbs NA, Twelves CJ, Gillies H, James CA, Harper PG, Rubens RD. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother Pharmacol. 1995;36(6):473.

    Article  PubMed  CAS  Google Scholar 

  73. Wade JR, Kelman AW, Kerr DJ, Robert J, Whiting B. Variability in the pharmacokinetics of epirubicin: a population analysis. Cancer Chemother Pharmacol. 1992;29(5):391.

    Article  PubMed  CAS  Google Scholar 

  74. Halm U, Schumann T, Schiefke I, Witzigmann H, Mossner J, Keim V. Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer. 2000;82(5):1013.

    Article  PubMed  CAS  Google Scholar 

  75. Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J. 2008;14(2):85.

    Article  PubMed  CAS  Google Scholar 

  76. Jann MW, ZumBrunnen TL, Tenjarla SN, Ward ES Jr, Weidler DJ. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences. Pharmacotherapy. 1998;18(2):288.

    PubMed  CAS  Google Scholar 

  77. Tsavaris N, Fountzilas G, Mylonakis N, et al. A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32-mg loading dose versus 8 mg every 6 h in patients undergoing cisplatin-based chemotherapy. Oncology. 1998;55(6):513.

    Article  PubMed  CAS  Google Scholar 

  78. Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L. Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1997;15(1):116.

    PubMed  CAS  Google Scholar 

  79. Hartvig Honore P. Molecular mechanisms in cytotoxic drug induced fatigue. Ann Pharm Fr. 2010;68(2):76.

    Article  PubMed  CAS  Google Scholar 

  80. Goldberg SL, Chiang L, Selina N, Hamarman S. Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies. Support Care Cancer. 2004;12(7):526.

    Article  PubMed  Google Scholar 

  81. Zalcberg J, Kerr D, Seymour L, Palmer M. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number Tomudex International Study Group. Eur J Cancer. 1998;34(12):1871.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic for Hematology and Oncology, Charité University Medicine, Berlin, Germany

    Oliver Schmetzer

  2. Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany

    Anne Flörcken

Authors
  1. Oliver Schmetzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Flörcken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver Schmetzer .

Editor information

Editors and Affiliations

  1. Charite´- Universitätsmedizin Berlin, Institute of Gender in Medicine (GiM), Berlin, 10115, Germany

    Sabine Oertelt-Prigione

  2. Inst. Geschlechterforschung in der, Medizin, Charité - Universitätsmedizin Berlin, Hessische Str. 3-4, Berlin, 10115, Germany

    Vera Regitz-Zagrosek

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Schmetzer, O., Flörcken, A. (2012). Sex and Gender Differences in Hematology. In: Oertelt-Prigione, S., Regitz-Zagrosek, V. (eds) Sex and Gender Aspects in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-832-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-832-4_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-831-7

  • Online ISBN: 978-0-85729-832-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation